Olivier Harismendy
University of California, San Diego
H-index: 39
North America-United States
Top articles of Olivier Harismendy
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
The selective WEE1 inhibitor azenosertib shows synergistic anti-tumor activity with KRASG12C inhibitors in multiple KRASG12C models | Cancer Research | Nathan M Jameson Gabriel Kim Catherine Lee Blake Skrable Alexandra Shea | 2024/3/22 |
Abstract B035: Cyclin E1 positive staining is frequent and independent of prior platinum treatment in high grade serous ovarian cancer | Cancer Research | Olivier Harismendy Heekyung Chung Astha Bhatia Adrian M Jubb Carrie Brownstein | 2024/3/4 |
Abstract A017: Prevalence and significance of common molecular alterations in Tp53-mutated uterine serous carcinoma | Clinical Cancer Research | Olivier Harismendy Jianhui Ma Adrian M Jubb Carrie Brownstein Mark R Lackner | 2024/3/1 |
Duration of Endocrine Treatment for DCIS impacts second events: Insights from a large cohort of cases at two academic medical centers | Research Square | Thomas O’Keefe Christina Yau Emma Iaconetti Eliza Jeong Case Brabham | 2024/1/11 |
Indicators of Response to the Wee1 Inhibitor Adavosertib in Acute Myeloid Leukemia | Blood | Ankita Srivastava Caroline A Heckman Juho Jalmari Miettinen Olivier Harismendy | 2023/11/28 |
Cyclin E1 protein overexpression sensitizes ovarian cancer cells to ZN-c3, a novel, selective and oral bioavailable inhibitor of Wee1 | Cancer Research | Jianhui Ma Wen Liu Heekyung Chung Hooman Izadi Petrus DeJong | 2023/4/4 |
Integrated Molecular Characterization of Intraductal Papillary Mucinous Neoplasms: An NCI Cancer Moonshot Precancer Atlas Pilot Project | Cancer Research Communications | Alexander Semaan Vincent Bernard Justin Wong Yuki Makino Daniel B Swartzlander | 2023/10/10 |
Bilateral mastectomy associated with higher breast cancer mortality among patients with estrogen receptor positive progesterone receptor negative localized breast cancer | Chinese Clinical Oncology | Thomas J O’Keefe Olivier Harismendy Anne M Wallace | 2023/2/28 |
Author Correction: Comprehensive analysis of chromothripsis in 2,658 human cancers using whole-genome sequencing | Nature genetics | Isidro Cortés-Ciriano Jake June-Koo Lee Ruibin Xi Dhawal Jain Youngsook L Jung | 2023/6 |
Author Correction: Pan-cancer analysis of whole genomes | Nature | 2023/2/16 | |
Correlation of cyclin E1 expression and clinical outcomes in a phase 1B dose-escalation study of azenosertib (ZN-C3), a WEE1 inhibitor, in combination with chemotherapy (CT) in … | J Clin Oncol | Joyce F Liu Siqing Fu Gary Edward Richardson Zivko Vranjes Tarek Meniawy | 2023/6/1 |
Whole-genome CRISPR screening identifies PI3K/AKT as a downstream component of the oncogenic GNAQ–focal adhesion kinase signaling circuitry | Journal of Biological Chemistry | Nadia Arang Simone Lubrano Damiano Cosimo Rigiracciolo Daniela Nachmanson Scott M Lippman | 2023/2/1 |
Assessing Unique Risk Factors for COVID-19 Complications Among Cancer Patients: A Multi-ethnic Cohort Study | Journal of immigrant and minority health | Hala T Borno Mi-Ok Kim Irina Tolstykh Amy Lin Julian C Hong | 2023/6 |
Tumor microenvironmental determinants of high-risk DCIS progression | bioRxiv | Alexa Glencer Kirithiga Ramalingam Nicole Schindler Hidetoshi Mori Prachi Ghule | 2023/12/4 |
Risk factors for breast cancer mortality after ductal carcinoma in situ diagnosis differ from those for invasive recurrence | Surgery | Thomas J O’Keefe Harrison Chau Olivier Harismendy Anne M Wallace | 2023/2/1 |
Germline modifiers of the tumor immune microenvironment implicate drivers of cancer risk and immunotherapy response | Nature communications | Meghana Pagadala Timothy J Sears Victoria H Wu Eva Pérez-Guijarro Hyo Kim | 2023/5/12 |
The breast pre-cancer atlas illustrates the molecular and micro-environmental diversity of ductal carcinoma in situ | NPJ Breast Cancer | Daniela Nachmanson Adam Officer Hidetoshi Mori Jonathan Gordon Mark F Evans | 2022/1/13 |
Abstract P5-06-02: A gene expression meta-analysis identifies microenvironment differences in cellular composition and cell-cell interactions associated with breast cancer invasion | Cancer Research | Adam Officer Andre Dempsey Farnaz Hasteh Michal Slyper Asa Segerstolpe | 2022/2/15 |
Stromal remodeling regulates dendritic cell abundance and activity in the tumor microenvironment | Cell reports | Athanasios Papadas Gauri Deb Alexander Cicala Adam Officer Chelsea Hope | 2022/8/16 |
Accurate genome-wide genotyping from archival tissue to explore the contribution of common genetic variants to pre-cancer outcomes | Journal of Translational Medicine | Daniela Nachmanson Meghana Pagadala Joseph Steward Callie Cheung Lauryn Keeler Bruce | 2022/12/27 |
Co-Authors
